Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
6.63
+0.19 (2.95%)
At close: Jun 12, 2026, 4:00 PM EDT
6.60
-0.03 (-0.45%)
After-hours: Jun 12, 2026, 7:51 PM EDT
Silo Pharma Revenue
Silo Pharma had revenue of $18.03K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $72.10K. In the year 2025, Silo Pharma had annual revenue of $72.10K.
Revenue (ttm)
$72.10K
Revenue Growth
n/a
P/S Ratio
99.72
Revenue / Employee
$24,034
Employees
3
Market Cap
7.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.10K | - | - |
| Dec 31, 2024 | 72.10K | - | - |
| Dec 31, 2023 | 72.10K | - | - |
| Dec 31, 2022 | 72.10K | 838.00 | 1.18% |
| Dec 31, 2021 | 71.26K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSILO News
- 12 days ago - Silo Pharma Inc trading halted, news pending - TheFly
- 5 weeks ago - Silo Pharma files provisional patent for ibogaine-based therapeutics - TheFly
- 5 weeks ago - Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - GlobeNewsWire
- 6 weeks ago - Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD - GlobeNewsWire
- 7 weeks ago - Silo Pharma expands into AI technology with Qwikagents asset purchase - TheFly
- 7 weeks ago - Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents - GlobeNewsWire
- 2 months ago - Silo Pharma gets European Patent Office allowance for PTSD prevention therapy - TheFly
- 2 months ago - Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy - GlobeNewsWire